| Property | Details |
|---|---|
| Source | Escherichia coli O45:K1 (strain S88/ExPEC) |
| Expression system | In vitro E. coli expression system |
| Molecular weight | Predicted ~16–18 kDa (exact mass depends on post-translational modifications) |
| Functional role | Stress adaptation, biofilm formation, virulence regulation |
| Associated pathways | Rcs phosphorelay system, purine biosynthesis |
uspB is critical for surviving hostile host environments:
Biofilm formation: Curli amyloid fibers, whose production is regulated by uspB, enhance biofilm formation in uropathogenic E. coli (UPEC) strains like O45:K1:H7. Biofilms confer resistance to cationic antimicrobial peptides (e.g., LL-37) and promote bladder colonization .
Stress adaptation: uspB interacts with the Rcs phosphorelay system and purine biosynthesis pathways to mitigate nutrient deprivation and oxidative stress .
Host colonization: Deletion of uspB in UPEC O45:K1:H7 attenuates bladder colonization in murine models, underscoring its role in pathogenesis .
E. coli O45:K1:H7 strains carrying uspB are part of the high-risk ST95 clonal group, which is implicated in:
Human infections: Neonatal meningitis, UTIs, and bacteremia .
Zoonotic transmission: Poultry serves as a reservoir for O45:K1:H7 strains, highlighting cross-species transmission risks .
| Trait | Mechanism | Clinical Impact |
|---|---|---|
| Curli production | Enhances biofilm formation and immune evasion | Chronic UTIs, antibiotic resistance |
| K1 capsule | Protects against serum killing | Neonatal meningitis |
| Iron acquisition | Utilizes siderophores (e.g., enterobactin) | Systemic infection persistence |
Pathogenesis studies: Used to dissect mechanisms of stress response and host-pathogen interactions .
Therapeutic target: Screening inhibitors of uspB could disrupt biofilm formation or virulence .
Diagnostic marker: Detected in ST95 strains causing severe infections, aiding epidemiological tracking .
Genetic screen identification: A forward genetic screen identified uspB as essential for curli synthesis in UPEC O45:K1:H7. Mutants lacking uspB failed to express CsgA (curli major subunit) and showed reduced virulence .
Cross-host pathogenicity: O45:K1:H7 strains from poultry and humans share ≥85% genomic identity, suggesting a common evolutionary origin .
Temperature-dependent expression: uspB-mediated curli production occurs at human physiological temperatures (37°C), aligning with host infection conditions .
KEGG: ecz:ECS88_3898
The Universal Stress Protein (UspA) superfamily encompasses a conserved group of proteins found in bacteria, archaea, and eukaryotes. E. coli harbors six well-characterized usp genes: uspA, uspC, uspD, uspE, uspF, and uspG, along with uspB. These genes are expressed in response to various environmental stressors, such as nutrient limitation, heat, oxidative agents, metals, and antibiotics . UspB belongs to this superfamily but has distinct structural and functional characteristics. Unlike the better-studied USPs, uspB requires specific experimental approaches for characterization due to its unique properties among the USP family.
USPs in bacterial systems typically exist in three structural configurations:
Small USP proteins (approximately 14-15 kDa) containing a single USP domain
Larger USPs (approximately 30 kDa) consisting of two USP domains in tandem
Complex USPs where the USP domain exists alongside other functional domains
Based on structural analysis and amino acid sequences, E. coli USPs are categorized into four distinct classes:
Class I: UspA, UspC, and UspD
Class II: UspF and UspG
Class III and IV: The two domains of UspE separate into these classes
While not explicitly classified in the available research, uspB likely belongs to one of these structural groups, requiring additional structural characterization to confirm its precise classification.
For optimal recombinant expression of uspB in E. coli, consider implementing the following protocol based on successful approaches for similar proteins:
Vector selection: Use a pET-based expression vector with an N-terminal His-tag for efficient purification.
Expression strain: BL21(DE3) or its derivatives are recommended for maximum yield.
Culture conditions:
Media optimization: Autoinduction media has been shown to enhance soluble protein expression compared to conventional IPTG induction for stress-related proteins .
Temperature management: Lower temperatures (18-25°C) during induction significantly increase soluble protein yields by reducing inclusion body formation, especially critical for stress-related proteins .
Based on successful approaches with similar proteins, the following purification strategy is recommended:
Cell lysis: Sonication or high-pressure homogenization in a buffer containing 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM imidazole, and 10% glycerol.
Initial purification: Ni-NTA affinity chromatography with:
Binding: 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM imidazole
Washing: Same buffer with 50 mM imidazole
Elution: Same buffer with 250-500 mM imidazole gradient
Tag removal: If a cleavable tag was incorporated, use TEV or thrombin protease (depending on the cleavage site engineered) to remove the His-tag .
Secondary purification: Size-exclusion chromatography using Superdex 75 or 200 in 20 mM Tris-HCl pH 7.5, 150 mM NaCl to achieve >85% purity .
Quality control: Verify protein purity by SDS-PAGE and confirm proper folding using circular dichroism spectroscopy.
To maximize biological activity, add 5-50% glycerol to the final purified protein and store at -80°C in small aliquots to avoid repeated freeze-thaw cycles .
Implementing a systematic experimental design approach can significantly enhance uspB expression yields. Consider the following strategy:
Factorial design: Establish a multifactorial experimental matrix examining:
Induction temperature (15°C, 25°C, 37°C)
Inducer concentration (0.1 mM, 0.5 mM, 1.0 mM IPTG)
Media composition (LB, TB, autoinduction)
Harvest time (4h, 8h, 16h, 24h post-induction)
Response surface methodology (RSM): After identifying significant factors, use RSM to find optimal parameter combinations.
Signal peptide screening: If periplasmic expression is desired, test multiple signal peptides (e.g., DsbA, Hbp, OmpA, PhoA) to identify the optimal targeting pathway .
Tunable expression systems: Consider using the rhamnose promoter system in a strain background with the rha operon deleted, which allows precise tuning of expression levels to match the cell's secretory capacity .
This systematic approach has enabled researchers to achieve yields of 250 mg/L for other recombinant proteins in E. coli with 75% homogeneity , providing a benchmark for uspB production optimization.
Based on functional studies of other USP family members, the following assays are recommended for characterizing uspB activity:
Oxidative stress resistance assays:
Iron homeostasis evaluation:
Cell aggregation and adhesion studies:
Motility assessment:
While specific functional data on uspB is limited in the provided sources, a comparative analysis with other USP family members reveals potential functional distinctions:
| USP Protein | Oxidative Stress Response | Iron Metabolism | Motility | Adhesion | Primary Function |
|---|---|---|---|---|---|
| UspA | Strong role in defense against superoxide | No significant role | No significant role | No significant role | Survival during growth arrest |
| UspD | Strong role in defense against superoxide | Important in controlling intracellular iron | No significant role | No significant role | Oxidative stress defense |
| UspC | No role in stress resistance | No role in iron metabolism | Essential for motility | Promotes motility over adhesion | Flagella development |
| UspE | Crucial for high concentrations of oxidants | No significant role | Essential for motility | Promotes motility over adhesion | Flagella development |
| UspF | Minor role in oxidative stress resistance | Minor role | No role in motility | Promotes adhesion over motility | Cell adhesion |
| UspG | Minor role in oxidative stress resistance | Minor role | No role in motility | Promotes adhesion over motility | Cell adhesion |
| UspB | ? | ? | ? | ? | Requires further characterization |
This table highlights the need for specific functional studies on uspB to determine its role within the USP family network .
Current research suggests that USPs, including potentially uspB, play crucial roles in bacterial pathogenesis and antimicrobial resistance through several mechanisms:
Stress-mediated resistance: USP expression is triggered by various stressors, including antibiotics, creating general resistance mechanisms .
Phagocytosis resistance: USPs have been implicated in helping bacteria resist macrophage phagocytosis, a critical virulence factor .
Biofilm formation: Through their effects on adhesion, USPs contribute to biofilm formation, which enhances antimicrobial resistance.
Metabolic adaptation: USPs help bacteria adapt metabolically during stress conditions, potentially enhancing survival during antibiotic exposure.
Research into uspB specifically may reveal unique contributions to these pathogenesis and resistance mechanisms, particularly in extraintestinal pathogenic E. coli (ExPEC) strains like O45:K1, which are associated with serious infections including neonatal meningitis and sepsis .
To identify critical functional residues in uspB, implement the following site-directed mutagenesis approach:
Sequence alignment and structural prediction:
Perform multiple sequence alignment with other USP family members
Use structural prediction tools to identify conserved domains and potential active sites
Focus on residues conserved across USPs with similar functions
Strategic mutation design:
Alanine scanning of conserved residues
Conservative and non-conservative substitutions at potential functional sites
Creation of chimeric proteins between uspB and other USPs to identify domain-specific functions
Functional assessment of mutants:
Express wild-type and mutant variants under identical conditions
Conduct comparative functional assays (oxidative stress response, adhesion, etc.)
Determine protein stability and structural changes using circular dichroism and thermal shift assays
This approach has successfully identified functional residues in other USPs and can elucidate the structure-function relationship of uspB .
Crystallizing uspB for structural studies presents several challenges that can be addressed through the following strategies:
Protein heterogeneity challenges:
Implement on-column refolding techniques during purification
Use size-exclusion chromatography as a final polishing step
Apply dynamic light scattering to verify monodispersity
Construct optimization:
Create truncated constructs to remove potentially disordered regions
Design fusion constructs with crystallization chaperones (T4 lysozyme, MBP, etc.)
Test both N- and C-terminal His-tags with various linker lengths
Crystallization condition screening:
Implement sparse matrix screens at multiple temperatures (4°C, 18°C)
Test both vapor diffusion and under-oil crystallization techniques
Add small molecules that may stabilize protein conformation
Alternative approaches if crystallization fails:
Nuclear Magnetic Resonance (NMR) for solution structure determination
Cryo-electron microscopy for structural analysis
Small-angle X-ray scattering (SAXS) for low-resolution envelope determination
These approaches have successfully yielded structures for other USP family members and could be adapted for uspB .
To comprehensively understand the uspB regulon, integrate transcriptomics and proteomics using the following approach:
Experimental design:
Generate uspB knockout, wild-type, and uspB-overexpressing strains
Subject strains to relevant stress conditions (oxidative stress, nutrient limitation)
Collect samples at multiple time points to capture dynamic responses
Multi-omics data collection:
RNA-seq to identify differentially expressed genes
Ribosome profiling to assess translational efficiency
Shotgun proteomics to quantify protein abundance changes
Phosphoproteomics to identify post-translational modifications
Integrated data analysis:
Correlate transcript and protein level changes
Identify potential direct targets through motif analysis
Construct gene regulatory networks using algorithms like WGCNA or ARACNE
Validate key interactions through ChIP-seq or similar techniques
Functional validation:
CRISPR interference to validate regulatory relationships
Promoter-reporter fusions to confirm direct regulation
Epistasis analysis between uspB and identified targets
This integrated approach will reveal the comprehensive regulatory network of uspB and its role in stress response coordination .
CRISPR-Cas9 technology offers powerful approaches for studying uspB function:
Precise genome editing:
Generate clean uspB knockout strains without polar effects
Create point mutations to study specific residues in the native genetic context
Insert reporter tags (fluorescent proteins, epitope tags) at the native locus
Regulatory studies using CRISPR interference (CRISPRi):
Design sgRNAs targeting the uspB promoter or coding region
Create tunable repression using dCas9 to generate a gradient of uspB expression
Implement multiplexed CRISPRi to simultaneously modulate uspB and related genes
High-throughput phenotypic screening:
Create CRISPR-based strain libraries with variations in uspB and related genes
Screen for phenotypes under various stress conditions
Implement Perturb-seq approaches to link genotype to transcriptional phenotypes
In vivo dynamics:
Use CRISPR-based imaging techniques to visualize uspB localization during stress
Create biosensors using dCas9-based systems to monitor uspB expression in real-time
This technology allows for unprecedented precision in studying uspB function across different genetic backgrounds and environmental conditions .
Based on the emerging understanding of USP functions, several promising antimicrobial strategies targeting USPs, including uspB, can be considered:
Direct inhibition approaches:
Structure-based design of small molecule inhibitors targeting conserved USP domains
Peptide inhibitors designed to disrupt USP protein-protein interactions
Allosteric modulators that prevent USP activation during stress
Potentiation strategies:
USP inhibitors as adjuvants to enhance conventional antibiotic efficacy
Compounds that interfere with stress-triggered USP upregulation
Targeting multiple USPs simultaneously to overcome functional redundancy
Virulence attenuation:
Inhibitors targeting USP-mediated adhesion to prevent colonization
Compounds disrupting USP-dependent biofilm formation
Modulators enhancing susceptibility to immune clearance
Resistance prevention:
Cycling between USP-targeting compounds and conventional antibiotics
Combination therapies targeting multiple bacterial stress response systems
Pre-emptive targeting of USPs to prevent stress-induced resistance development
These approaches represent novel antibiotic development strategies that could address the growing challenge of antimicrobial resistance by targeting bacterial stress response systems rather than essential functions .
Synthetic biology offers innovative ways to harness engineered uspB variants for biotechnological applications:
Biosensing applications:
Engineer uspB-based whole-cell biosensors for detecting environmental stressors
Develop reporter systems using uspB promoters to monitor cellular stress in industrial bioprocesses
Create tunable genetic circuits with uspB as a stress-responsive element
Improved recombinant protein production:
Develop engineered E. coli strains with modified uspB expression for enhanced stress tolerance during protein production
Create feedback loops linking uspB activation to reduced recombinant protein expression rate, preventing cellular overload
Incorporate uspB-based stress detection systems into bioreactor control algorithms
Bioremediation applications:
Engineer bacteria with enhanced uspB functionality for improved survival in contaminated environments
Develop strains with modified uspB systems optimized for specific pollutants
Create consortia with complementary uspB variant functions for complex bioremediation challenges
Therapeutic probiotics:
Engineer probiotic strains with modified uspB to enhance survival in the gastrointestinal tract
Develop strains with uspB variants optimized for specific inflammatory conditions
Create targeted delivery systems using uspB-based stress sensing for site-specific therapeutic release
These applications leverage the natural stress-responsive properties of uspB within engineered biological systems to address various biotechnological challenges .